Caris Life Sciences is committed to bringing awareness to sarcoma cancers. During Sarcoma Awareness Month, we are focused on educating individuals about the importance of molecular profiling in changing the course of treatment. Learn more about how Caris testing can make a difference: https://ow.ly/4jYE50StOrx #SarcomaAwarenessMonth
Caris Life Sciences’ Post
More Relevant Posts
-
We are advancing azenosertib, our WEE1 inhibitor candidate, which has the potential to address large, unmet need across an array of cancers. Learn more about #azenosertib here: https://bit.ly/3Q3ATwI.
To view or add a comment, sign in
-
A cancer-fighting discovery at Mayo Clinic has set the stage for biomanufacturing operations. Dr. Qin and his team have developed a new type of therapy that aims to kill blood cancers that don't respond to other treatments. Read more here: https://bit.ly/41zTkgC #JaxChamberHealthCouncil #HealthCouncil #HealthcareJax #JaxChamber
To view or add a comment, sign in
-
-
❓ How is prefibrotic primary #myelofibrosis diagnosed and managed? 📝 The latest Society of Hematologic Oncology State of the Art: Updates and Next Questions by Pankit Vachhani, Sanam Loghavi, and Prithviraj Bose lends insight into this distinct myeloproliferative neoplasm. ➡️ https://buff.ly/3VcRznS
To view or add a comment, sign in
-
Through collaboration and partnerships, Verastem is developing novel approaches for RAS pathway-driven cancers, providing hope and expanded treatment options. Learn more about how combinations of avutometinib and defactinib can enhance treatment efficacy: bit.ly/3FoMJLu
To view or add a comment, sign in
-
Interesting and thorough analysis of extrachromosomal DNA which appears to correlate with worse outcome in GI cancers treated with anti-PD1 alone but better outcomes with chemo-immotherapy. https://lnkd.in/gMNjrAPW
To view or add a comment, sign in
-
MPNs are a closely related group of rare progressive blood cancers in which the bone marrow typically overproduces one of the mature blood elements. Learn more about MPNs here: https://lnkd.in/gdmQSuVX #mpnawareness #worldcancerawarenessday #cancerawareness #bloodcancerawareness #rarecancerawareness
To view or add a comment, sign in
-
-
#ESMOGI24: #ColorectalCancer (CRC) can be classified into two groups based on its ability to repair DNA microsatellite damage. Tumours that are mismatch repair-deficient and have high levels of microsatellite instability (MSI) have shown remarkable responses to immunotherapy, particularly checkpoint inhibitors. On the other hand, tumours that are mismatch repair-proficient and microsatellite stable (MSS) have a lower mutational burden and have historically been less responsive to immunotherapeutic strategies. To learn more about overcoming barriers to immunotherapy for microsatellite stable #ColorectalCancer, read the Opinion by Myriam Chalabi in the #ESMODailyReporter. 📌https://ow.ly/OwGl50SqFVq
To view or add a comment, sign in
-
-
📢 $ARAY - New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System https://lnkd.in/gsreehhA For Quick News, Spikes and Movers: https://lnkd.in/dX4HFAGS
To view or add a comment, sign in
-
🔬 Interested in understanding more about #MRD in #cancertreatment? 🧐 MRD stands for Minimal Residual Disease, a technique to detect cancer cells even when they're not visible under a microscope. Learn how MRD can guide treatment decisions and predict remission length in this insightful discussion. #CancerResearch #TreatmentGuidance #FoamEd #MedEd #CME
To view or add a comment, sign in